Skip to main content
Back to feed
MarketsSingle-sourceLow
2.1

AstraZeneca Chairman Buys 2,500 Shares in Insider Purchase

AstraZeneca chairman Michel Demaré purchased 2,500 shares at £121.21, a routine insider transaction. The purchase is small relative to market cap and likely signals confidence, but has no material market impact.

Dagens Industriabout 3 hours agoGBCredibility 26%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3

Intelligence Tags

#insider-trading#pharmaceuticals#equities

Entities

country
Source

Related signals

8 found